监督运动疗法对PAD患者运动血压和心率的影响及与步行改善的关联
该随机临床试验事后分析纳入210例外周动脉疾病(PAD)患者,比较6个月监督运动疗法(SET)与对照组对平板运动试验中血压和心率变化的影响。结果显示SET显著降低运动时收缩压、脉压和心率,且这些改善与6分钟步行距离和最大平板步行距离的提升相关。
要点
- SET可显著降低PAD患者运动时收缩压、脉压和心率。
- 运动时血压和心率下降程度与步行能力改善程度相关。
- SET可能通过改善心血管健康提升PAD患者步行表现。
核心结论
- 在PAD患者中,与对照组相比,SET改善了以运动时血压和心率变化衡量的心血管健康。
- 心血管健康的改善程度与步行表现的改善程度相关。
研究设计与样本
- 随机临床试验的事后分析,210例PAD患者随机分入SET组(每周3次)或对照组(每周1次健康讲座),干预6个月。
- 176例完成基线和6个月随访的平板运动试验,年龄67±9岁,女性72例(41%),黑人115例(65%)。
主要发现
- 与对照组相比,SET组6个月随访时平板运动试验前5阶段总体平均收缩压降低12 mm Hg(P < .001),脉压降低9 mm Hg(P < .001),心率降低7 b/min(P < .01),舒张压无显著变化。
- SET组中,运动时收缩压下降越大与6分钟步行距离改善(r = -0.19,P = .03)和最大平板步行距离改善(r = -0.21,P < .01)相关。
- SET组中,脉压下降越大与6分钟步行距离改善(r = -0.23,P < .01)和最大平板步行距离改善(r = -0.17,P = .03)相关。
- SET组中,心率下降越大与6分钟步行距离改善(r = -0.21,P < .01)和WIQ距离评分改善(r = -0.27,P = .03)相关。
临床怎么用
- 对于PAD患者,可考虑采用监督运动疗法以改善运动时血压和心率反应。
- 运动时血压和心率改善程度可作为步行能力改善的参考指标。
局限性
- 本研究为事后分析,结果需谨慎解读。
- 仅176例完成随访平板运动试验,存在失访偏倚可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Supervised exercise therapy (SET) improves walking ability in people with peripheral artery disease (PAD). However, the effects of SET on cardiovascular health in PAD remain unclear. Using data from a randomized clinical trial, this post hoc analyses investigated the effects of a 6-month SET intervention, compared with a control group, on changes in blood pressure (BP) and heart rate (HR) during a graded treadmill exercise test in people with PAD. METHODS: We randomized 210 participants with PAD to either SET (3× weekly) or control (1× weekly health lectures) for 6 months. A graded treadmill exercise test, 6-minute walk test, and Walking Impairment Questionnaire were completed at baseline and the 6-month follow-up. BP and HR were measured at the end of each 2-minute stage of the graded treadmill exercise test. Mixed effects regression models compared the overall mean 6-month change in systolic BP, diastolic BP, pulse pressure (PP), and HR during the first 5 stages of the graded treadmill exercise test between groups. RESULTS: Of the 210 randomized participants with PAD, 176 (67 ± 9 years; 72 [41%] female, 115 [65%] Black) completed the graded treadmill exercise test at baseline and the 6-month follow-up. Compared with the control group at the 6-month follow-up, SET significantly decreased overall mean systolic BP (-12 mm Hg; P < .001), PP (-9 mm Hg; P < .001), and HR (-7 b/min; P < .01) during a graded treadmill exercise test but not diastolic BP. Among participants randomized to SET, a greater decrease in systolic BP, PP, and HR during a graded treadmill exercise test was significantly associated with a greater improvement in 6-minute walk distance (systolic BP, r = -0.19 [P = .03] and PP, r = -0.23 [P < .01]; and HR, r = -0.21 [P < .01]) and with maximal treadmill walking distance (systolic BP, r = -0.21 [P < .01] and PP, r = -0.17 [P = .03]) at the 6-month follow-up. A greater decrease in the HR during a graded treadmill exercise test was significantly associated with a better WIQ distance score (r = -0.27; P = .03) at the 6-month follow-up. CONCLUSIONS: In people with PAD, compared with a control group, SET improved cardiovascular health, measured by changes in BP and HR during exercise. The degree of improvement in cardiovascular health correlated with the degree of improvement in walking performance in people with PAD. NCT: 01408901.
引用
- Slysz JT, Tian L, Zhao L, et al. Effects of supervised exercise therapy on blood pressure and heart rate during exercise, and associations with improved walking performance in peripheral artery disease: Results of a randomized clinical trial. J Vasc Surg. 2021. PMID: 34090987. doi:10.1016/j.jvs.2021.05.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。